The Lancet. Respiratory medicine

The most recent articles from: Lancet Respir Med May 2016

Lancet Respir Med · May 2016

Meta Analysis

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis.

Gastro-oesophageal reflux disease is a potential risk factor for the development and progression of idiopathic pulmonary fibrosis (IPF). We aimed to investigate the effect of antacid therapy on disease progression in patients randomly assigned to placebo through analysis of three large, phase 3 trials of pirfenidone in IPF. ⋯ F Hoffmann-La Roche.

explore further… or not…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,706,642 articles already indexed!